CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment

CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment

CCL22 is a macrophage-derived immunosuppressive chemokine that recruits regulatory T cells through the CCL22:CCR4 axis. CCL22 was shown to play a key role in suppressing anti-cancer immune responses in different cancer types. Recently, we showed that CCL22-specific T cells generated from cancer pati...

Full description

Bibliographic Details
Main Authors: Inés Lecoq, Katharina L. Kopp, Marion Chapellier, Panagiotis Mantas, Evelina Martinenaite, Maria Perez-Penco, Lars Rønn Olsen, Mai-Britt Zocca, Ayako Wakatsuki Pedersen, Mads Hald Andersen
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:OncoImmunology
Subjects:
CCL22
peptide vaccine
tumor microenvironment
immune modulation
immunotherapy
Online Access:https://www.tandfonline.com/doi/10.1080/2162402X.2022.2115655

Internet

https://www.tandfonline.com/doi/10.1080/2162402X.2022.2115655

Similar Items